ROSATOM together with the Ministry of Health of the Kyrgyz Republic completed the key stage of the project to establish a new radionuclide diagnostics department at the National Center for Oncology and Hematology (NCHO) in Bishkek. The parties are developing interaction within the framework of the IAEA technical cooperation program, which aims to develop advanced nuclear medicine technologies in Kyrgyzstan.
ROSATOM delivered a technetium-99m GT-4K generator to NCHO. This isotope is used in more than 80% of procedures on the single-photon emission computed tomography (SPECT) machine that has been delivered to the new department.
These medical devices are used for diagnostics in oncological, cardiological, neuroendocrine and other diseases. ROSATOM specialists provide all necessary support to their Kyrgyz colleagues to train doctors in SPECT diagnostics with technetium-99m. The next step is to obtain a license from the Kyrgyz Republic regulatory authorities for the project’s compliance with radiation safety requirements, and for the use of radioisotope products.
The center will offer an opportunity for Kyrgyzstan residents with cancer and other socially significant diseases to get access to high-tech medical diagnostics using the capabilities of the peaceful atom.
“We are happy to provide full support to our Kyrgyz partners in preparation for the commissioning of the new radionuclide diagnostics department. This project is vital for the development of atomedics in the Republic of Kyrgyzstan and our further strategic cooperation. We donated the technetium generator to our Kyrgyz colleagues for training doctors. In the future, ROSATOM is ready to fully meet the needs of the Kyrgyz Republic in technetium-99m generators,” said Igor Obrubov, Director General of Rusatom Healthcare, the ROSATOM’s division.
Background:
In June 2023, ROSATOM and the Republic of Kyrgyzstan signed a Memorandum of Cooperation in the field of non-energy application of nuclear technologies in healthcare. The parties agreed to jointly develop high-tech medical projects in Kyrgyzstan. In particular, this involves the creation of a radiopharmaceutical pharmacy, a center for molecular imaging and a center for targeted therapy and theranostics based on the National Center for Oncology and Hematology (NCOH), where advanced methods of diagnostics and treatment of oncological and other diseases will be applied. The parties are already cooperating in issues of equipment supplies and commissioning of the single-photon emission computed tomography department established under the IAEA technical cooperation program. Russian specialists assist Kyrgyz colleagues in the preparation of the necessary authorization documentation.
About 2.5 million of diagnostic and therapeutic procedures in Russia and abroad can be performed with ROSATOM radioisotope medical products. Diagnostics with the use of radiopharmaceutical products enables early detection of any diseases and timely commencement of therapy.
Technetium-99m is the most demanded isotope in nuclear medicine. Technetium-99m generators are used for diagnostics in oncologic, cardiologic, neuroendocrine and other diseases.
Leave a Reply